Filing Details
- Accession Number:
- 0001415889-23-006617
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-18 16:33:52
- Reporting Period:
- 2023-04-14
- Accepted Time:
- 2023-04-18 16:33:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-14 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-14 | 3,463 | $227.90 | 4,667 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-14 | 3,692 | $228.65 | 975 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-14 | 513 | $229.37 | 462 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-14 | 332 | $231.39 | 130 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-04-17 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-17 | 3,040 | $230.02 | 5,090 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-17 | 4,581 | $230.68 | 509 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-17 | 379 | $231.54 | 130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2023-04-14 | 8,000 | $0.00 | 8,000 | $113.08 |
| Common Stock | Stock Options | Disposition | 2023-04-17 | 8,000 | $0.00 | 8,000 | $113.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 96,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
| 88,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 166 | Indirect | By Spouse |
| Common Stock | 644,183 | Indirect | By Trusts |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.
- This transaction was executed in multiple trades at prices ranging from $227.23 to $228.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $228.235 to $229.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $229.325 to $229.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $230.90 to $231.865. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $229.335 to $230.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $230.34 to $231.335. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $231.39 to $231.625. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
